Kenneth Bate - Insider Trading & Ownership

Location
C/O Millennium Pharmaceuticals Inc, 40 Landsdowne Street, Cambridge, MA
Summary
The estimated net worth of Kenneth Bate is at least $1.32M dollars as of November 7, 2025. Kenneth Bate is the Director of MADRIGAL PHARMACEUTICALS, INC. and owns shares of MADRIGAL PHARMACEUTICALS, INC. (MDGL) stock worth about $1.29M. Kenneth Bate is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K. Kenneth Bate is the Director of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $5.63K.
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Kenneth Bate

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MDGL MADRIGAL PHARMACEUTICALS, INC. Director $1.29M -$18.8M -93.6% Nov 5, 2025
EPZM Epizyme, Inc. Director $23K Aug 12, 2022
AVEO AVEO PHARMACEUTICALS, INC. Director $5.63K Jan 19, 2023
ATXS Astria Therapeutics, Inc. Director Jun 11, 2025
GNCA GENOCEA BIOSCIENCES, INC. Director Jul 1, 2021

Insider Transactions Reported by Kenneth Bate:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.